120 related articles for article (PubMed ID: 36965981)
1. Invasive cervical cancer, precancerous lesions, and cervical screening participation among women with mental illness in Sweden: a population-based observational study.
Hu K; Wang J; Sparén P; Herweijer E; Sjölander A; Adami HO; Valdimarsdóttir U; Sundström K; Fang F
Lancet Public Health; 2023 Apr; 8(4):e266-e275. PubMed ID: 36965981
[TBL] [Abstract][Full Text] [Related]
2. Clinical Practice Guidelines on the Screening and Treatment of Precancerous Lesions for Cervical Cancer Prevention in Saudi Arabia.
Al-Mandeel HM; Sagr E; Sait K; Latifah HM; Al-Obaid A; Al-Badawi IA; Alkushi AO; Salem H; Massoudi NS; Schunemann H; Mustafa RA; Brignardello-Petersen R
Ann Saudi Med; 2016; 36(5):313-320. PubMed ID: 27710981
[TBL] [Abstract][Full Text] [Related]
3. Precancerous lesion determinants in women attending cervical cancer screening at public health facilities in North Shoa Zone, Amhara, Ethiopia: an unmatched case-control study.
Teklehaimanot DA; Mekuria AD; Dadi AF; Derseh BT
BMC Womens Health; 2024 May; 24(1):271. PubMed ID: 38702683
[TBL] [Abstract][Full Text] [Related]
4. Cervical screening with primary HPV testing or cytology in a population of women in which those aged 33 years or younger had previously been offered HPV vaccination: Results of the Compass pilot randomised trial.
Canfell K; Caruana M; Gebski V; Darlington-Brown J; Heley S; Brotherton J; Gertig D; Jennett CJ; Farnsworth A; Tan J; Wrede CD; Castle PE; Saville M
PLoS Med; 2017 Sep; 14(9):e1002388. PubMed ID: 28926579
[TBL] [Abstract][Full Text] [Related]
5. Intensified screening among high risk women within the organised screening programme for cervical cancer in Finland.
Kotaniemi-Talonen L; Malila N; Anttila A; Nieminen P; Hakama M
Acta Oncol; 2011 Jan; 50(1):106-11. PubMed ID: 20560860
[TBL] [Abstract][Full Text] [Related]
6. Histopathological profile of cervical punch biopsies and risk factors associated with high-grade cervical precancerous lesions and cancer in northwest Ethiopia.
Derbie A; Amare B; Misgan E; Nibret E; Maier M; Woldeamanuel Y; Abebe T
PLoS One; 2022; 17(9):e0274466. PubMed ID: 36094938
[TBL] [Abstract][Full Text] [Related]
7. [Real-world research on cervical cancer screening program and effect evaluation for Chinese population].
Zhao YQ; Dai Y; Dang L; Kong LH; Zhang Y; Feng RM; Qiao YL; Lang JH
Zhonghua Zhong Liu Za Zhi; 2018 Oct; 40(10):764-771. PubMed ID: 30392341
[No Abstract] [Full Text] [Related]
8. Participation in a Swedish cervical cancer screening program among women with psychiatric diagnoses: a population-based cohort study.
Eriksson EM; Lau M; Jönsson C; Zhang C; Risö Bergerlind LL; Jonasson JM; Strander B
BMC Public Health; 2019 Mar; 19(1):313. PubMed ID: 30885177
[TBL] [Abstract][Full Text] [Related]
9. High rates of cervical cancer among HIV-infected women at a referral hospital in Malawi.
Kohler RE; Tang J; Gopal S; Chinula L; Hosseinipour MC; Liomba NG; Chiudzu G
Int J STD AIDS; 2016 Aug; 27(9):753-60. PubMed ID: 26130691
[TBL] [Abstract][Full Text] [Related]
10. Immediate referral to colposcopy versus cytological surveillance for minor cervical cytological abnormalities in the absence of HPV test.
Kyrgiou M; Kalliala IE; Mitra A; Fotopoulou C; Ghaem-Maghami S; Martin-Hirsch PP; Cruickshank M; Arbyn M; Paraskevaidis E
Cochrane Database Syst Rev; 2017 Jan; 1(1):CD009836. PubMed ID: 28125861
[TBL] [Abstract][Full Text] [Related]
11. [Health technology assessment report: HPV DNA based primary screening for cervical cancer precursors].
Ronco G; Biggeri A; Confortini M; Naldoni C; Segnan N; Sideri M; Zappa M; Zorzi M; Calvia M; Accetta G; Giordano L; Cogo C; Carozzi F; Gillio Tos A; Arbyn M; Mejier CJ; Snijders PJ; Cuzick J; Giorgi Rossi P
Epidemiol Prev; 2012; 36(3-4 Suppl 1):e1-72. PubMed ID: 22828243
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of human papillomavirus testing for the detection of invasive cervical cancers and cervical intraepithelial neoplasia: a randomised controlled trial.
Ronco G; Giorgi-Rossi P; Carozzi F; Confortini M; Dalla Palma P; Del Mistro A; Ghiringhello B; Girlando S; Gillio-Tos A; De Marco L; Naldoni C; Pierotti P; Rizzolo R; Schincaglia P; Zorzi M; Zappa M; Segnan N; Cuzick J;
Lancet Oncol; 2010 Mar; 11(3):249-57. PubMed ID: 20089449
[TBL] [Abstract][Full Text] [Related]
13. Improving Cervical Precancer Surveillance: Validity of Claims-Based Prediction Models in ICD-9 and ICD-10 Eras.
Shing JZ; Griffin MR; Nguyen LD; Slaughter JC; Mitchel EF; Pemmaraju M; Rentuza AB; Hull PC
JNCI Cancer Spectr; 2021 Feb; 5(1):. PubMed ID: 33554035
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials.
Ronco G; Dillner J; Elfström KM; Tunesi S; Snijders PJ; Arbyn M; Kitchener H; Segnan N; Gilham C; Giorgi-Rossi P; Berkhof J; Peto J; Meijer CJ;
Lancet; 2014 Feb; 383(9916):524-32. PubMed ID: 24192252
[TBL] [Abstract][Full Text] [Related]
15. Increased Risk of High-grade Cervical Neoplasia in Women with Inflammatory Bowel Disease: A Case-controlled Cohort Study.
Goetgebuer RL; Kreijne JE; Aitken CA; Dijkstra G; Hoentjen F; de Boer NK; Oldenburg B; van der Meulen AE; Ponsioen CIJ; Pierik MJ; van Kemenade FJ; de Kok IMCM; Siebers AG; Manniën J; van der Woude CJ; de Vries AC
J Crohns Colitis; 2021 Sep; 15(9):1464-1473. PubMed ID: 33609353
[TBL] [Abstract][Full Text] [Related]
16. Accuracy of visual inspection with acetic acid to detect cervical cancer precursors among HIV-infected women in Kenya.
Huchko MJ; Sneden J; Sawaya G; Smith-McCune K; Maloba M; Abdulrahim N; Bukusi EA; Cohen CR
Int J Cancer; 2015 Jan; 136(2):392-8. PubMed ID: 24889387
[TBL] [Abstract][Full Text] [Related]
17. Primary high-risk HPV screening for cervical cancer in post-menopausal women.
Gyllensten U; Gustavsson I; Lindell M; Wilander E
Gynecol Oncol; 2012 May; 125(2):343-5. PubMed ID: 22293044
[TBL] [Abstract][Full Text] [Related]
18. Performance of p16INK4a ELISA as a primary cervical cancer screening test among a large cohort of HIV-infected women in western Kenya: a 2-year cross-sectional study.
Wu TJ; Smith-McCune K; Reuschenbach M; von Knebel Doeberitz M; Maloba M; Huchko MJ
BMJ Open; 2016 Sep; 6(9):e012547. PubMed ID: 27625065
[TBL] [Abstract][Full Text] [Related]
19. Effect of Screening With Primary Cervical HPV Testing vs Cytology Testing on High-grade Cervical Intraepithelial Neoplasia at 48 Months: The HPV FOCAL Randomized Clinical Trial.
Ogilvie GS; van Niekerk D; Krajden M; Smith LW; Cook D; Gondara L; Ceballos K; Quinlan D; Lee M; Martin RE; Gentile L; Peacock S; Stuart GCE; Franco EL; Coldman AJ
JAMA; 2018 Jul; 320(1):43-52. PubMed ID: 29971397
[TBL] [Abstract][Full Text] [Related]
20. The current position and the future perspectives of cervical cancer screening.
Bosgraaf RP; Siebers AG; De Hullu JA; Massuger LF; Bulten J; Bekkers RL; Melchers WJ
Expert Rev Anticancer Ther; 2014 Jan; 14(1):75-92. PubMed ID: 24308681
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]